Pharmaceutical Supplies Procurement for Indian Army Injectables and Vaccines

Work Description - NA

This tender presents a crucial opportunity for the supply of essential pharmaceutical products to the Department of Military Affairs, Indian Army, under the Ministry of Defence. The bid, identified by number GEM/2026/B/7740584, is scheduled to commence on August 14, 2026, at 12:00 PM and will conclude on August 17, 2026, at 12:00 PM. This procurement, titled "CDL DRUGS," encompasses a diverse and significant requirement for various injectable medications and vaccines, with a total quantity of 101,155 units. Key items listed include Anti D 150mcg Injection, Budesonide 200 mcg Inhaler (240 metered doses), Inj docarvim and Miromavimab 1500IU 2.5M TWIN RAB, Inj Human Rabies Immunoglobulin (300 IU 150MG 2 ML), Inj Labetalol 20mg, Inj Phenytoinsodium 100mg, Inj Tetanus Toxoid Vaccine 0.5ml, and Inj Vit B1B6 and B12 Neurobion, alongside Labetalol HCl 5mg/ml 4ml Injection. The Department of Military Affairs, based in Panchkula, is seeking qualified and reliable suppliers capable of meeting these specific medical supply needs.